title: Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS).
authors.forename: Christian
authors.initials: C
authors.lastname: Sticherling
authors.forename: Francisco
authors.initials: F
authors.lastname: Marin
authors.forename: David
authors.initials: D
authors.lastname: Birnie
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Boriani
authors.forename: Hugh
authors.initials: H
authors.lastname: Calkins
authors.forename: Gheorghe-Andrei
authors.initials: GA
authors.lastname: Dan
authors.forename: Michele
authors.initials: M
authors.lastname: Gulizia
authors.forename: Sigrun
authors.initials: S
authors.lastname: Halvorsen
authors.forename: Gerhard
authors.initials: G
authors.lastname: Hindricks
authors.forename: Karl-Heinz
authors.initials: KH
authors.lastname: Kuck
authors.forename: Angel
authors.initials: A
authors.lastname: Moya
authors.forename: Tatjana
authors.initials: T
authors.lastname: Potpara
authors.forename: Vanessa
authors.initials: V
authors.lastname: Roldan
authors.forename: Roland
authors.initials: R
authors.lastname: Tilz
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D001208:Asia; D002309:Cardiology / Q000592:standards*; D004334:Drug Administration Schedule; D022062:Electrophysiologic Techniques, Cardiac / Q000009:adverse effects* / Q000592:standards*; D005060:Europe; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D017410:Practice Guidelines as Topic; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents
keywords: Ablation; Anticoagulation bleeding; Antithrombotic therapy; Atrial fibrillation; Bridging; Cardiac implantable electronical devices; Electrophysiology